Metastatic Breast Carcinoma Clinical Trials

79 clinical trials for Metastatic Breast Carcinoma across international registries, including 24 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer — RECRUITING · PHASE2
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer — RECRUITING · PHASE2
• Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors — RECRUITING · PHASE1
• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax — RECRUITING · PHASE1
• Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer — RECRUITING · PHASE1
• A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer — RECRUITING · PHASE2
• An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis — RECRUITING · PHASE4
• Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain — RECRUITING · PHASE3
• Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial — RECRUITING · PHASE3
• Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer — RECRUITING
• Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial — RECRUITING · PHASE2
• 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer — RECRUITING · PHASE2
• Intravital Microscopy in Human Solid Tumors — RECRUITING · NA
• DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients — RECRUITING
• Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer — RECRUITING · PHASE2
• [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer — RECRUITING · PHASE1
• Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. — RECRUITING · PHASE2
• Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer — RECRUITING · NA
• Living Well With Advanced Breast Cancer — RECRUITING
• Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer — RECRUITING · PHASE2
• Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer — RECRUITING
• Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer — RECRUITING · PHASE2
• Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors — RECRUITING
• Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer — RECRUITING · PHASE2
• Paclitaxel Therapeutic Drug Monitoring in Cancer Patients — SUSPENDED
• Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations — ACTIVE_NOT_RECRUITING · PHASE2
• Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) — SUSPENDED · PHASE2
• Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic — ACTIVE_NOT_RECRUITING · PHASE3
• Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer — ACTIVE_NOT_RECRUITING
• Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival — COMPLETED · PHASE2
• Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study — ACTIVE_NOT_RECRUITING · PHASE2
• Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial — ACTIVE_NOT_RECRUITING · PHASE1
• Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy — ACTIVE_NOT_RECRUITING
• Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring — SUSPENDED
• Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer — ACTIVE_NOT_RECRUITING
• Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones — NOT_YET_RECRUITING · PHASE1
• PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery — COMPLETED · PHASE1
• A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer — ACTIVE_NOT_RECRUITING · NA
• Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases — COMPLETED · PHASE2
• An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer — TERMINATED · NA
• Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer — TERMINATED · PHASE1
• Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• MBC Physical Activity Study — COMPLETED · NA
• Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer — TERMINATED · PHASE1

Refine this search